Filing Flows › Sonoma Pharmaceuticals (SNOA) › Q4 FY26 › vs Q3 FY26
Sonoma Pharmaceuticals (SNOA) Q4 FY26 vs Q3 FY26 (quarter over quarter)
Sonoma Pharmaceuticals's revenue rose $1.2M (+28%) from $4.3M in Q3 FY26 to $5.6M in Q4 FY26.
Sonoma Pharmaceuticals, Q4 FY26: revenue $5.6M (+48% year over year), operating margin -6.3%, net loss $581K, operating cash flow −$519K. The chart draws each line against Q3 FY26, the increases inside each band.
Every line
| Line | Q4 FY26 | Q3 FY26 | Change | % |
|---|---|---|---|---|
| Revenue | $5.6M | $4.3M | $1.2M | +28% |
| Net loss | $581K | $819K | −$238K | -29% |
| Costs & expenses | $6.1M | $5.3M | $844K | +16% |
| Operating costs | $5.9M | $5.0M | $885K | +18% |
| Interest & other, net | $146K | $271K | −$125K | -46% |
| Income tax | $84K | −$130K | $214K | — |
| Cost of revenue | $3.4M | $2.7M | $681K | +25% |
| Research & development | $545K | $557K | −$12K | -2% |
| SG&A | $2.0M | $1.8M | $216K | +12% |
| Operating cash sources | $687K | $822K | −$135K | -16% |
| Depreciation & amortization | $33K | $34K | −$1K | -3% |
| Share-based compensation | $135K | $24K | $111K | +462% |
| Cash used in operations | $519K | $764K | −$245K | -32% |
| Net loss absorbed | $581K | $819K | −$238K | -29% |
| Working capital & other | $106K | $3K | $103K | 35× |
Questions
How much did Sonoma Pharmaceuticals's revenue grow quarter over quarter in Q4 FY26?
Sonoma Pharmaceuticals's revenue rose $1.2M (+28%) from $4.3M in Q3 FY26 to $5.6M in Q4 FY26.